Literature DB >> 30444015

Safety and efficacy of patiromer use with tacrolimus in kidney transplant recipients.

Rungwasee Rattanavich1, Andrew F Malone1, Tarek Alhamad1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30444015     DOI： 10.1111/tri.13369

Source DB:  PubMed          Journal:  Transpl Int        ISSN： 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  4 in total

1.  Pre-Transplant Plasma Potassium as a Potential Risk Factor for the Need of Early Hyperkalaemia Treatment after Kidney Transplantation: A Cohort Study.

Authors:  Bram C S de Vries; Stefan P Berger; Stephan J L Bakker; Martin H de Borst; Margriet F C de Jong
Journal:  Nephron       Date:  2020-11-19       Impact factor: 2.847

Review 2.  Clinical Efficacy, Safety, Tolerability, and Real-World Data of Patiromer for the Treatment of Hyperkalemia.

Authors:  Gates Colbert; Shilpa Sannapaneni; Edgar V Lerma
Journal:  Drug Healthc Patient Saf       Date:  2022-07-14

Review 3.  Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options.

Authors:  Enrique Morales; Paolo Cravedi; Joaquin Manrique
Journal:  Front Med (Lausanne)       Date:  2021-06-04

4.  Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway.

Authors:  Shumin Zhang; Huafen Wang; Yifei Liu; Wenxia Yang; Jialu Liu; Yuzhang Han; Yu Liu; Fuyou Liu; Lin Sun; Li Xiao
Journal:  J Cell Mol Med       Date:  2020-08-11       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.